Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the effectiveness of the combination of abemaciclib and fulvestrant in treating this type of cancer and to determine the types and severity of side effects caused by treatment with abemaciclib and fulvestrant.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03643510
Study type Interventional
Source Memorial Sloan Kettering Cancer Center
Contact
Status Active, not recruiting
Phase Phase 2
Start date August 21, 2018
Completion date August 2026